| ID1 |
ID1, ID: DNA-binding protein inhibitor ID-1 |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
0.265 |
Evidence |
|
| MMP12 |
MMP12, HME: Macrophage metalloelastase precursor |
STAB2 |
STAB2, FEEL2, FELL, FEX2, HARE: Stabilin-2 precursor |
0.265 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
MC1R |
IPI00552844 |
0.265 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
GPR12 |
GPR12: Probable G-protein coupled receptor 12 |
0.265 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
TPSG1 |
TPSG1, PRSS31, TMT: Tryptase gamma precursor |
0.265 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
HTRA1 |
HTRA1, HTRA, PRSS11: Serine protease HTRA1 precursor |
0.265 |
Evidence |
|
| SERPINB5 |
|
KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
0.265 |
Evidence |
|
| ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.265 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
NCOA2 |
NCOA2, TIF2: Nuclear receptor coactivator 2 |
0.265 |
Evidence |
|
| TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
ADAMTS8 |
ADAMTS8, METH2: ADAMTS-8 precursor |
0.265 |
Evidence |
|
| TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
ADAMTS5 |
ADAMTS5, ADAMTS11, ADMP2: ADAMTS-5 precursor |
0.265 |
Evidence |
|
| TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
MMP28 |
MMP28, MMP25, UNQ1893/PRO4339: Matrix metalloproteinase-28 precursor |
0.265 |
Evidence |
|
| TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
MMP14 |
MMP14: Matrix metalloproteinase-14 precursor |
0.265 |
Evidence |
O
|
| SCN4A |
SCN4A: Sodium channel protein type 4 subunit alpha |
SCN8A |
SCN8A, MED: Sodium channel protein type 8 subunit alpha |
0.265 |
Evidence |
|
| TNFSF8 |
TNFSF8, CD30L, CD30LG: Tumor necrosis factor ligand superfamily member 8 |
TNFRSF11A |
TNFRSF11A, RANK: Tumor necrosis factor receptor superfamily member 11A precursor |
0.265 |
Evidence |
|
| TNFSF8 |
TNFSF8, CD30L, CD30LG: Tumor necrosis factor ligand superfamily member 8 |
TNFRSF9 |
TNFRSF9, CD137, ILA: Tumor necrosis factor receptor superfamily member 9 precurs |
0.265 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.265 |
Evidence |
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.265 |
Evidence |
|
| CHRNB4 |
CHRNB4: Neuronal acetylcholine receptor subunit beta-4 precursor |
GABRG3 |
GABRG3: Gamma-aminobutyric acid receptor subunit gamma-3 precursor |
0.265 |
Evidence |
|
| CHRNB4 |
CHRNB4: Neuronal acetylcholine receptor subunit beta-4 precursor |
CHRNA6 |
CHRNA6: Neuronal acetylcholine receptor subunit alpha-6 precursor |
0.265 |
Evidence |
|
| CHRNB4 |
CHRNB4: Neuronal acetylcholine receptor subunit beta-4 precursor |
CHRNB3 |
CHRNB3: Neuronal acetylcholine receptor subunit beta-3 precursor |
0.265 |
Evidence |
|
| SSTR2 |
SSTR2: Somatostatin receptor type 2 |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.265 |
Evidence |
|
| SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
GZMM |
GZMM, MET1: Granzyme M precursor |
0.265 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.265 |
Evidence |
|
| ADORA1 |
ADORA1: Adenosine receptor A1 |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.265 |
Evidence |
|